RGNX
NASDAQ HealthcareREGENXBIO Inc. - Common Stock
Biotechnology
📊 Market Data
| Price | $9.08 |
|---|---|
| Volume | 685,490 |
| Market Cap | 459.66M |
| Beta | 1.140 |
| RSI (14-Day) | 57.8 |
| 200-Day MA | $10.58 |
| 50-Day MA | $11.24 |
| 52-Week High | $16.19 |
| 52-Week Low | $5.04 |
| Forward P/E | -4.17 |
| Price / Book | 4.50 |
🎯 Investment Strategy Scores
How RGNX scores across each investment strategy. Higher is better for that strategy's goals.
💰 Dividend Daddy
22/100
High dividend yield + low volatility
🚀 Moon Shot
38/100
High growth potential (high beta + oversold)
🔪 Falling Knife
43/100
Contrarian plays (oversold + below moving average)
🎈 Over-Hyped
83/100
Overbought stocks (potential short candidates)
🐋 Institutional Whale
12/100
Large-cap, institutional-quality stocks
Find RGNX in your text
Paste any text on the homepage — the tool will extract RGNX and other hidden tickers.
Disclaimer: This data is for educational and entertainment purposes only and does not constitute financial advice. Market data may be delayed. Always do your own research before making investment decisions.